Monopar Therapeutics (MNPR) Retained Earnings (2016 - 2025)
Quarterly results put Retained Earnings at -$89.5 million for Q4 2025, down 248766.37% from a year ago — trailing twelve months through Dec 2025 was -$89.5 million (down 248766.37% YoY), and the annual figure for FY2025 was -$89.5 million, down 248766.37%.
Monopar Therapeutics has reported Retained Earnings over the past 9 years, most recently at -$89.5 million for Q4 2025.
- Retained Earnings reached -$89.5 million in Q4 2025 per MNPR's latest filing, down from $11698.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $42985.0 in Q3 2022 and bottomed at -$89.5 million in Q4 2025.
- Median Retained Earnings over the past 5 years was -$42.5 million (2021), compared with a mean of -$37.8 million.
- The largest annual shift saw Retained Earnings tumbled 857815.38% in 2022 before it soared 206.43% in 2025.
- Over 5 years, Retained Earnings stood at -$41.3 million in 2021, then fell by 25.47% to -$51.8 million in 2022, then decreased by 16.22% to -$60.2 million in 2023, then soared by 100.06% to $35992.0 in 2024, then tumbled by 248766.37% to -$89.5 million in 2025.
- Business Quant data shows Retained Earnings for MNPR at -$89.5 million in Q4 2025, $11698.0 in Q3 2025, and -$80.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 36.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 130.89 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | -89.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -89.50 Mn |
| Sep 30, 2025 | 11,698.00 |
| Jun 30, 2025 | -80.90 Mn |
| Mar 31, 2025 | -78.40 Mn |
| Dec 31, 2024 | 35,992.00 |
| Sep 30, 2024 | -10,991.00 |
| Jun 30, 2024 | -63.56 Mn |
| Mar 31, 2024 | -61.80 Mn |
| Dec 31, 2023 | -60.21 Mn |
| Sep 30, 2023 | 3,949.00 |
| Jun 30, 2023 | -56.44 Mn |
| Mar 31, 2023 | -54.24 Mn |
| Dec 31, 2022 | -51.80 Mn |
| Sep 30, 2022 | 42,985.00 |
| Jun 30, 2022 | 17,466.00 |
| Mar 31, 2022 | -43.75 Mn |
| Dec 31, 2021 | -41.29 Mn |
| Sep 30, 2021 | -38.61 Mn |
| Jun 30, 2021 | -36.15 Mn |
| Mar 31, 2021 | -5,099.00 |
| Dec 31, 2020 | -32.19 Mn |
| Sep 30, 2020 | -10,044.00 |
| Jun 30, 2020 | -28.42 Mn |
| Mar 31, 2020 | -15,011.00 |
| Dec 31, 2019 | -25.88 Mn |
| Sep 30, 2019 | -24.67 Mn |
| Jun 30, 2019 | -3,456.00 |
| Mar 31, 2019 | -4,523.00 |
| Dec 31, 2018 | -2,396.00 |
| Sep 30, 2018 | -2,385.00 |
| Jun 30, 2018 | -1,579.00 |
| Mar 31, 2018 | -19.30 Mn |
| Dec 31, 2016 | -1.87 Mn |